Inventor · disambiguated record
Elliot K. Chartash
Also filed as: CHARTASH ELLIOT · CHARTASH ELLIOT K · CHARTASH ELLIOT KEITH
14 granted patents·39 pending applications·156 citations·filing 2002–2023
94Inventor score
Files withABBVIE BIOTECHNOLOGY LTD19ABBOTT BIOTECH LTD8HOFFMAN REBECCA S4ABBOTT LAB S A3MERCK SHARP & DOHME3
Top patents by PatentIndex Score
53 records- 0194US9090689B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 28, 2015·13 cites·21 claims
- 0294US8906373B2Use of TNF-alpha inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 9, 2014·20 cites·9 claims
- 0394US8889136B2Multiple-variable dose regimen for treating TNFα-related disordersHOFFMAN REBECCA S·Filed 2005·Granted Nov 18, 2014·25 cites·18 claims
- 0493US9085620B1Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 21, 2015·12 cites·30 claims
- 0593US8986693B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 24, 2015·14 cites·8 claims
- 0693US8961974B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·28 claims
- 0793US8961973B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·30 claims
- 0892US9187559B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 17, 2015·8 cites·30 claims
- 0990US9512216B2Use of TNFα inhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Dec 6, 2016·5 cites·16 claims
- 1090US9499615B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 22, 2016·5 cites·28 claims
- 1190US9061005B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseHOFFMAN REBECCA S·Filed 2012·Granted Jun 23, 2015·10 cites·28 claims
- 1288US7776331B1Methods of treating plaque psoriasisABBOTT LAB·Filed 2008·Granted Aug 17, 2010·16 cites·67 claims
- 1377US2021347875A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1477US2021347874A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1572US8557239B2Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23VALDES JOAQUIN MARIO·Filed 2010·Granted Oct 15, 2013·4 cites·18 claims
- 1671US2020017580A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2019·Application pending·0 cites
- 1768US2019055308A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 1867US2014286940A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1967US2014286941A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2067US2008193466A1Treatment of Anemia Using TNFalpha InhibitorsABBOTT BIOTECH LTD·Filed 2008·Application pending·0 cites
- 2167US2014286939A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2266US2009304682A1Multiple-variable dose regimen for treating TNFa-related disordersHOFFMAN REBECCA S·Filed 2008·Application pending·0 cites
- 2365US2017022271A1Multiple-variable dose regimen for treating tnfalpha-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Application pending·0 cites
- 2464US2013243763A1TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIESBANERJEE SUBHASHIS·Filed 2013·Application pending·0 cites
- 2562US2025000994A1Combination therapies for the treatment of non-small cell lung cancerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2662US2015368335A1Treatment of tnf-alpha related disordersABBOTT BIOTECH LTD·Filed 2015·Application pending·0 cites
- 2761US2017044249A1MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERSABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2860US2016376360A9Use of TNFalpha InhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2959US2025000990A1Combination therapies for the treatment of cancerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3058US2004136991A1Treatment of anemia using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3158US2004131614A1Treatment of pulmonary disorders using TNFalpha inhibitorABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3258US2004126372A1Treatment of TNFalpha related disordersABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3358US2004126373A1Treatment of coronary disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3458US2004151722A1Treatment of metabolic disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3558US2004136990A1Treatment of pain using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3657US2004219142A1Treatment of skin and nail disorders using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3757US2013243786A1Treatment of juvenile rheumatoid arthritis (jra)BANERJEE SUBHASHIS·Filed 2003·Application pending·0 cites
- 3857US2024150467A1Compositions and methods for treating cancer with subcutaneous administration of anti-pd1 antibodiesMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3957US2004136989A1Treatment of vasculitides using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 4057US2007202104A1Treatment of spondyloarthropathies using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 4154US2021317214A1Combination therapy of a pd-1 antagonist and lag3 antagonist for treating patients with non-microsatellite instability-high or proficient mismatch repair colorectal cancerMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 4253US2014079714A1Methods for treating psoriasisVALDES JOAQUIN MARIO·Filed 2013·Application pending·0 cites
- 4351US2004009172A1Use of anti-TNFalpha antibodies and another drugFISCHKOFF STEVEN·Filed 2003·Application pending·0 cites
- 4450US2021347889A1Dosing regimen of anti-lag3 antibody and combination therapy with anti-pd-1 antibody for treating cancerMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 4550US2025074983A1Methods for treating cancer with subcutaneous administration of anti-pd1 antibodiesLALA MALLIKA·Filed 2022·Application pending·0 cites
- 4649US2006083741A1Treatment of respiratory syncytial virus (RSV) infectionHOFFMAN REBECCA S·Filed 2005·Application pending·0 cites
- 4747US9051368B2Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23CHARTASH ELLIOT KEITH·Filed 2010·Granted Jun 9, 2015·0 cites·20 claims
- 4846US2023192876A1Dosing regimen of anti-cd27 antibodies for treatment of cancerMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 4945US2015050216A1Uses and Compositions for Treatment of PsoriasisWILLIAN MARY KAYE·Filed 2014·Application pending·0 cites
- 5041US2003206898A1Use of anti-TNFalpha antibodies and another drugFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Elliot K. Chartash files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →